Market Insights Health OTC Pharmaceuticals

Eye Care - Central Asia

Central Asia

In Central Asia, the revenue generated in the Eye Care market market in 2024 amounts to US$27.74m.
It is projected to experience an annual growth rate of 5.50% (CAGR 2024-2029).
When comparing globally, the in the United States leads in generating the highest revenue in this market, with US$1,256.00m in 2024.
In terms of per person revenues, US$0.35 is generated in 2024.
Central Asia's eye care market is witnessing a surge in demand for OTC pharmaceuticals, driven by increasing awareness about eye health and accessibility to affordable products.

Key regions: Europe, Australia, Brazil, China, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Eye Care market in Central Asia has been experiencing significant growth in recent years. Customer preferences for eye care products and services have evolved, leading to new trends in the market. Additionally, local special circumstances and underlying macroeconomic factors have contributed to the development of the Eye Care market in Central Asia.Customer preferences in the Eye Care market have shifted towards a greater emphasis on preventive care and overall eye health. Consumers are becoming more aware of the importance of regular eye examinations and are seeking out products and services that can help maintain good vision. This has led to an increased demand for eyeglasses, contact lenses, and other vision correction solutions. Additionally, there is a growing interest in natural and organic eye care products, as consumers are becoming more conscious of the ingredients used in these products.Trends in the Eye Care market in Central Asia include the rising popularity of online eyewear retailers. Consumers are increasingly turning to online platforms to purchase eyeglasses, contact lenses, and other eye care products. The convenience and wide selection offered by online retailers have attracted a large customer base. Furthermore, advancements in technology have made it easier for consumers to measure their own prescription and order eyewear online.Another trend in the market is the increasing demand for specialized eye care services. As the population ages, there is a growing need for treatments and procedures related to age-related eye conditions, such as cataracts and glaucoma. This has led to the establishment of specialized eye care clinics and hospitals that offer advanced treatments and surgeries.Local special circumstances in Central Asia, such as a high prevalence of certain eye conditions, have also contributed to the development of the Eye Care market. For example, the region has a relatively high incidence of myopia, which has driven the demand for corrective eyewear. Additionally, the harsh climate in some parts of Central Asia, including extreme temperatures and high levels of UV radiation, has increased the need for eye protection products, such as sunglasses and UV-blocking contact lenses.Underlying macroeconomic factors, such as a growing middle class and increasing disposable income, have also played a role in the development of the Eye Care market in Central Asia. As more people have access to healthcare and disposable income, they are able to prioritize their eye health and invest in eye care products and services. Furthermore, government initiatives to improve access to healthcare and increase awareness about eye health have also contributed to the growth of the market.In conclusion, the Eye Care market in Central Asia has experienced significant growth due to evolving customer preferences, new market trends, local special circumstances, and underlying macroeconomic factors. As consumers become more aware of the importance of eye health and have greater access to healthcare, the market is expected to continue growing in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.